Ellagitannins are large polyphenolic compounds found in pomegranate, berries, nuts and some woods. When you eat these foods, the ellagitannins are hydrolyzed in the stomach and small intestine to release ellagic acid, a smaller phenolic molecule that can be acted upon by the microbes living in your colon.
Only a subset of gut bacteria can further break down ellagic acid through a stepwise series of reactions that ultimately yield urolithin A (UA). This conversion depends on the composition of your microbiota, dietary context, and even co‑administered prebiotic fibers. Understanding the microbial pathway helps explain why some people produce high levels of UA while others do not.
Key Takeaways
- Ellagitannins are hydrolyzed to ellagic acid, which reaches the colon largely unchanged.
- A defined set of gut bacteria performs stepwise dehydroxylation to turn ellagic acid into urolithin A.
- People differ in their “urolithin metabotype”; only metabotype A consistently makes urolithin A.
- Prebiotic fibers (e.g., FOS) and certain probiotic strains can boost UA production in low‑producer individuals.
- Absorbed UA circulates as conjugated metabolites; its bioavailability is modest but biologically relevant.
Ellagitannins → Ellagic Acid: The First Chemical Shift
Ellagitannins are ester-linked polymers of hexahydroxydiphenic acid and glucose. In the acidic environment of the stomach and the enzymatic milieu of the small intestine, these polymers are cleaved, releasing free ellagic acid (EA) [1]. The released EA is poorly absorbed in the upper gut, allowing most of it to reach the colon where microbial metabolism begins.
The Core Microbial Steps: From Ellagic Acid to Urolithin A
Gut bacteria convert EA to UA through a series of dehydroxylation and decarboxylation reactions. The pathway can be simplified into three major stages:
1. **Ring‑opening and dehydroxylation** – Certain bacteria remove hydroxyl groups from EA, producing intermediate urolithins such as urolithin M5 and urolithin C [2].
2. **Further dehydroxylation** – Additional bacterial enzymes strip more hydroxyl groups, generating urolithin D and finally urolithin A, which retains a single hydroxyl group on the benzene ring [5].
3. **Reduction and conjugation** – The final UA may be reduced to its dihydro form or conjugated with glucuronic acid or sulfate before absorption, but the core structure remains unchanged.
Key Bacterial Players and Metabotypes
Not everyone harbors the same UA‑producing microbes. Researchers have identified at least three “urolithin metabotypes” based on which urolithins appear in urine after ellagitannin consumption. Metabotype A individuals consistently produce UA as the final product, while metabotypes B and 0 produce earlier intermediates or none at all [2].
In vitro work with gut samples from metabotype A donors showed that a limited set of bacterial strains—including members of the genera *Gordonibacter*, *Ellagibacter*, and *Bifidobacterium*—can complete the full conversion of EA to UA [5]. Other taxa, such as *Eggerthella* spp., may stall the pathway at intermediate urolithins, explaining the variability among people.
Factors That Enhance UA Production
Dietary components can shift the microbial community toward UA‑producing species. Co‑administration of fructooligosaccharides (FOS) with ellagic acid markedly increased UA yields in human volunteers, likely by promoting the growth of beneficial fermenters that support the conversion steps [7].

Fermentation studies also demonstrated that adding the probiotic *Streptococcus thermophilus* FUA329 to fecal cultures improved UA output across different metabotypes, suggesting that targeted microbial supplementation could overcome a low‑producer status [3].
In vivo, consuming pomegranate juice enriched the UA‑producing phenotype and altered bile‑acid metabolism, linking UA production to broader metabolic effects in overweight individuals [4].
From Colon to Circulation: Absorption and Bioavailability
Once formed, UA is absorbed primarily in the colon via passive diffusion. It appears in plasma mainly as glucuronide or sulfate conjugates, which are more water‑soluble and can circulate to peripheral tissues [9]. The bioavailability of UA is modest (estimated 10‑15 % of the amount produced), but the circulating conjugates retain biological activity and can be de‑conjugated in target cells.
Food matrix and digestion also matter. Simulated gastrointestinal digestion followed by fermentation of ellagic‑acid‑rich fruit polyphenols preserved the UA‑producing microbiota and resulted in higher post‑fermentation UA levels than direct EA supplementation, emphasizing the importance of whole‑food context [6].
Why Production Varies: Host and Microbial Interplay
Age, diet, medication, and health status shape the gut ecosystem. Post‑menopausal women, for example, showed different UA‑related metabolic responses when their diet was supplemented with polyphenols, highlighting that hormonal and metabolic background can modulate the microbial conversion [8].
Antibiotic exposure can temporarily suppress UA‑producing strains, reducing UA appearance in urine for weeks after treatment. Conversely, a diet rich in fiber and polyphenols supports a diverse microbiota, increasing the likelihood of a metabotype A profile.
Where to Find Urolithin A
- Urolithin A supplements on Amazon (generic, budget-friendly)
- Mitopure by Timeline (the clinically studied branded form)
As an Amazon Associate we earn from qualifying purchases.
A Note on the Evidence
Urolithin A production varies widely among individuals; current evidence is based on laboratory and short‑term human studies, not long‑term clinical outcomes. People with gut disorders or on antibiotics should discuss dietary changes with a healthcare provider.
Frequently Asked Questions
What foods provide the ellagitannins needed for urolithin A production?
Ellagitannins are abundant in pomegranate juice and seeds, strawberries, raspberries, blackberries, walnuts, and some oak‑derived foods. Eating these foods supplies the ellagic acid precursor for microbial conversion [1].
Can I take ellagic acid supplements instead of eating whole foods?
Supplements deliver ellagic acid directly, but studies show that whole‑food matrices often support better microbial conversion, likely because they provide additional fibers and co‑metabolites that nurture UA‑producing bacteria [6].
Why do some people not produce urolithin A even after eating pomegranate?
The absence of key bacterial strains defines metabotype 0 or B, which stops the pathway at earlier intermediates. Individual microbiota composition, diet, and recent antibiotic use are major determinants [2].
Do prebiotic fibers really increase urolithin A levels?
Yes. Clinical work demonstrated that fructooligosaccharides taken together with ellagic acid significantly raised urinary UA, indicating enhanced microbial synthesis [7].
Is urolithin A absorbed into the bloodstream?
After production in the colon, UA is absorbed as glucuronide or sulfate conjugates and appears in plasma at low concentrations. These conjugates can be de‑conjugated in target tissues and retain activity [9].

Should I try probiotic supplements to become a urolithin A producer?
Specific strains like *Streptococcus thermophilus* FUA329 have been shown in vitro to improve UA yields when co‑fermented with fecal microbiota, but human trials are limited. Consult a healthcare professional before starting any new probiotic regimen.
References
- Saha P et al. Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme Peroxidases. PloS one (2016). PMID 27254317
- García-Villalba R et al. Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota. Molecular nutrition & food research (2022). PMID 35118817
- Xia M et al. Improvement of Urolithin A Yield by In Vitro Cofermentation of Streptococcus thermophilus FUA329 with Human Gut Microbiota from Different Urolithin Metabotypes. Journal of agricultural and food chemistry (2024). PMID 38301119
- Cortés-Martín A et al. Urolithin A production drives the effects of pomegranate on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals. Food & function (2024). PMID 38329279
- He F et al. In vitro conversion of ellagic acid to urolithin A by different gut microbiota of urolithin metabotype A. Applied microbiology and biotechnology (2024). PMID 38363367
- Xie Z et al. Bioactive release and modulation of urolithin metabotype A phenotype gut microbiota during in vitro digestion and fermentation of ellagic acid-rich fruit polyphenols. Food & function (2025). PMID 40679425
- Zhang L et al. Fructooligosaccharides and ellagic acid synergistically enhance muscular endurance via targeting gut microbial urolithin A biosynthesis. Journal of advanced research (2026). PMID 41506451
- Jarrín-Orozco MP et al. Precision health targeting TMAO in postmenopausal women: polyphenol effects modulated by urolithin A and equol metabotypes in a randomised, placebo-controlled crossover trial. Food & function (2026). PMID 41642121
- Yuan H et al. Urolithin A From Gut Metabolite to Therapeutic Agent: Bioavailability, Mechanisms, and Translational Insights. Journal of food science (2026). PMID 41866331


